Cority Bolsters Leadership With Appointment of Ted Kail as the New Chief Product Officer 8-02-2023, 20:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Teledyne introduces next generation AI-powered smart camera for industrial automation and inspection 26-09-2024, 19:00